• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

Global Hepatitis Treatment and Diagnostics

$995.00 – $1,990.00

Clear
SKU: KLI1517677 Category: Pharmaceuticals Market Research Pages: 200
  • Description
  • Table of Contents
  • Latest reports

Description

The unrecognized importance, danger and costs of hepatitis in the 21st century cannot be understated or underestimated. The impact of the disease on world society is highly significant and now presenting a major crisis in public health circles.

In his exhaustive analysis of the potential diagnosis, screening and therapeutic markets for hepatitis, Ken Krul, PhD. advises companies to think on a global basis. In this study, Global Hepatitis Strategies Krul examines the potential market, epidemiology (hepatitis patient trends) and technology to provide a clear understanding of the opportunities and challenges awaiting companies competing in this market.

As part of the market analysis this report includes

  • Extensive Statistics of Incidence and Prevalence of Hepatitis Across the 6 Major WHO Regions (Americas, Europe, Africa, Western Pacific, Southeast Asia, Eastern Mediterranean)
  • Etiology, Prophylaxis, and Therapy for Hepatitis A, B, C, D and E.
  • Theoretical Revenues for Diagnosis, Screening and Therapeutics representing the potential marketplace if all screening options are pursued.
  • Realistic Market Revenues representing the likely marketplace.
  • Global Distribution of Therapeutics and Diagnostics Revenues across Major 6 WHO regions
  • Over 40 Figures and Tables making information accessible.

Product managers, Marketing executives at pharmaceutical and diagnostic companies; as well as investment professionals are among those who will find this survey a critical resource.

Table of Contents

TABLE OF CONTENTS

CHAPTER ONE: EXECUTIVE SUMMARYMarket Potential

Epidemiology

Technology

Scope and Methodology

CHAPTER TWO: THE BASICS OF HEPATITIS, VIRUSES, ETIOLOGY AND PATHOLOGY

Hepatitis A

 

  • The Virus
  • Etiology
  • Pathology

 

Hepatitis B

 

  • The Virus
  • Etiology Pathology

 

Hepatitis C

 

  • The Virus
  • Etiology
  • Pathology

 

Hepatitis D

 

  • The Virus
  • Etiology
  • Pathology

 

Hepatitis E

 

  • The Virus
  • Etiology
  • Pathology

 

CHAPTER THREE: EPIDEMILOGY

Hepatitis A

 

  • Geographic Patterns
  • Age of Infection
  • U.S. Hepatitis A Cases

 

Hepatitis B

 

  • Geographic Patterns
  • Risk to Children and Infants
  • Vaccines

 

Hepatitis C

 

  • Geographic Patterns

 

Hepatitis D

 

  • Geographic Patterns

 

Hepatitis E

 

  • Geographic Patterns

 

CHAPTER FOUR: HEPATITIS DIAGNOSIS, PROPHYLAXIS AND THERAPEUTICS

Hepatitis A

 

  • Diagnosis
  • Prophylaxis
  • Therapeutics

 

Hepatitis B

 

  • Diagnosis
  • Prophylaxis
  • Therapy

 

Hepatitis C

 

  • Diagnosis
  • Prophylaxis
  • Therapy

 

Hepatitis D

 

  • Diagnosis
  • Prophylaxis
  • Therapy

 

Hepatitis E

 

  • Diagnosis
  • Prophylaxis
  • Therapy

 

CHAPTER FIVE: STRATEGIC ASSESSMENT AND MARKET ANALYSIS

Hepatitis Policy

Comprehensive Prevention Strategy

Hepatitis C Prevention

Market Potential

Theoretical Market Assessment

Diagnostics and Screening Markets

Therapeutics: Vaccines and Antivirals

Pricing Considerations

Realistic Market Assessment

TABLE OF EXHIBITS

CHAPTER ONE: EXECUTIVE SUMMARY

Table 1-1: Estimated Theoretical Global Market Potentials for Hepatitis (All Types) Testing Products and Therapeutics: 2006

Figure 1-1: Theoretical Distribution of Global Hepatitis (All Types) Testing Products and Therapeutics Market Potential: 2006

Table 1-2: Estimated Theoretical Global Market Potentials for Hepatitis (All Types) Testing Products: 2006 (Millions)

Figure 1-2: Theoretical Distribution of Global Hepatitis (All Types) Testing Products (Screening and Diagnosis) Market Potential: 2006

Table 1-3: Estimated Theoretical Global Market Potentials for Hepatitis (All Types) Therapeutics: 2006

Figure 1-3: Theoretical Distribution of Global Hepatitis (All Types) Therapeutic Products Market Potential: 2006

Table 1-4: A Realistic Estimation Global Market Potentials for Hepatitis (All Types) Testing Products and Therapeutics: 2006 (Millions)

Figure 1-4 The Distribution of Realistic Estimates of Global Hepatitis (All Types) Testing Products and Therapeutics Market Potential: 2006

Table 1-5 A Realistic Estimation Global Market Potentials for Hepatitis (All Types) Testing Products: 2006 (Millions)

Figure 1-5: The Distribution of Realistic Estimates of Global Hepatitis (All Types) Testing Products Market Potential: 2006

Table 1-6 A Realistic Estimation Global Market Potentials for Hepatitis (All Types) Therapeutics: 2006

Figure 1-6 The Distribution of Realistic Estimates of Global Hepatitis (All Types) Therapeutics Market Potential: 2006

Table 1-7: Global Prevalence of Hepatitis (All Types): 2006 (Millions)

Figure 1-7: The Distribution of Global Hepatitis (All Types) Prevalence: 2006

CHAPTER TWO: THE BASICS OF HEPATITIS, VIRUSES, ETIOLOGY AND PATHOLOGY

Table 2-1 The Hepatitis Viruses

CHAPTER THREE: EPIDEMILOGY

Table 3-1 Worldwide Endemicity of HAV Infection

Table 3-2: Prevalence of Hepatitis B in Various regions of the World

Table 3-3: Hepatitis C Estimated Prevalence and Number Infected by WHO Region: 2000

Table 3-2: Prevalence of Hepatitis B in Various regions of the World

CHAPTER FOUR: HEPATITIS DIAGNOSIS, PROPHYLAXIS AND THERAPEUTICS

Table 4-1: HBV Serological Markers in Hepatitis Patients

Table 4-2: Commercially Available HBV (Antigen and Antibody) Assays

Table 4-3: Significance of Serological Marker Tests for HBV (HBsAg, antiHBs, anti HBc and Interpretation)

Table 4-4: Serological Test Findings at Different Stages of HBV Infection and in Convalescence

Table 4-5: Key Hepatitis B Vaccines* Available Internationally (Producer, Vaccine, Country, Type)

Table 4-6: General Description of Useful Assay Technologies in the Diagnosis of Hepatitis C

Table 4-7 Commercially Available HCV (Antigen and Antibody) Assays

CHAPTER FIVE: STRATEGIC ASSESSMENT AND MARKET ANALYSIS

Table 5-1: Estimated Theoretical Global Market Potentials for Hepatitis (All Types) Testing Products and Therapeutics: 2006

Figure 5-1: Theoretical Distribution of Global Hepatitis (All Types) Testing Products and Therapeutics Market Potential: 2006

Table 5-2: Estimated Theoretical Global Market Potentials for Hepatitis (All Types) Testing Products: 2006

Figure 5-2: Theoretical Distribution of the Total Global Hepatitis (All Types) Testing Products Market Potential: 2006

Figure 5-3: Theoretical Distribution of Global Hepatitis (All Types) Testing Products Market Potential for Screening: 2006

Figure 5-4: Theoretical Distribution of Global Hepatitis (All Types) Testing Products Market Potential for Diagnosis: 2006

Table 5-3: Estimated Theoretical Global Market Potentials for Hepatitis (All Types) Therapeutics: 2006

Figure 5-5: Theoretical Distribution of Global Hepatitis (All Types) Therapeutic Products Market Potential: 2006

Figure 5-6: Theoretical Distribution of Global Hepatitis (All Types) Vaccine Market Potential: 2006

Figure 5-7: Theoretical Distribution of Global Hepatitis (All Types) Antiviral Drug Market Potential: 2006

Table 5-4: A Realistic Estimation Global Market Potentials for Hepatitis (All Types) Testing Products and Therapeutics: 2006 (in millions)

Figure 5-8: The Distribution of Realistic Estimates of Global Hepatitis (All Types)

Testing Products and Therapeutics Market Potential: 2006

Table 5-5: A Realistic Estimation Global Market Potentials for Hepatitis (All Types) Testing Products: 2006

Figure 5-9: The Distribution of Realistic Estimates of Global Hepatitis (All Types) Market Potential for Testing Products: 2006

Figure 5-10: The Distribution of Realistic Estimates of Global Hepatitis (All Types)

Market Potential for Testing Products in Screening: 2006

Figure 5-11: The Distribution of Realistic Estimates of Global Hepatitis (All Types)

Market Potential for Testing Products in Diagnosis: 2006

Table 5-6: A Realistic Estimation Global Market Potentials for Hepatitis (All Types) Therapeutics: 2006

Figure 5-12: The Distribution of Realistic Estimates of Global Hepatitis (All Types) Therapeutics Market Potential: 2006

Figure 5-13: The Distribution of Realistic Estimates of Global Hepatitis (All Types)

Therapeutics Market Potential — Vaccines: 2006

Figure 5-14: The Distribution of Realistic Estimates of Global Hepatitis (All Types) Therapeutics Market Potential — Antiviral Drugs: 2006

Table 5-1: Estimated Theoretical Global Market Potentials for Hepatitis (All Types) Testing Products and Therapeutics: 2006

Figure 5-1: Theoretical Distribution of Global Hepatitis (All Types) Testing Products and Therapeutics Market Potential: 2006

Table 5-2: Estimated Theoretical Global Market Potentials for Hepatitis (All Types) Testing Products: 2006

Figure 5-2: Theoretical Distribution of the Total Global Hepatitis (All Types) Testing Products Market Potential: 2006

Figure 5-3: Theoretical Distribution of Global Hepatitis (All Types) Testing Products Market Potential for Screening: 2006

Figure 5-4: Theoretical Distribution of Global Hepatitis (All Types) Testing Products Market Potential for Diagnosis: 2006

Table 5-3: Estimated Theoretical Global Market Potentials for Hepatitis (All Types) Therapeutics: 2006

Figure 5-5: Theoretical Distribution of Global Hepatitis (All Types) Therapeutic Products Market Potential: 2006

Figure 5-6: Theoretical Distribution of Global Hepatitis (All Types) Vaccine Market Potential: 2006

Figure 5-7 Theoretical Distribution of Global Hepatitis (All Types) Antiviral Drug Market Potential: 2006

Table 5-4: A Realistic Estimation Global Market Potentials for Hepatitis (All Types) Testing Products and Therapeutics: 2006

Figure 5-8: The Distribution of Realistic Estimates of Global Hepatitis (All Types) Testing Products and Therapeutics Market Potential: 2006

Table 5-5: A Realistic Estimation Global Market Potentials for Hepatitis (All Types) Testing Products: 2006

Figure 5-9: The Distribution of Realistic Estimates of Global Hepatitis (All Types) Market Potential for Testing Products: 2006

Figure 5-10: The Distribution of Realistic Estimates of Global Hepatitis (All Types) Market Potential for Testing Products in Screening: 2006

Figure 5-11: The Distribution of Realistic Estimates of Global Hepatitis (All Types)

Market Potential for Testing Products in Diagnosis: 2006

Table 5-6: A Realistic Estimation Global Market Potentials for Hepatitis (All Types) Therapeutics: 2006

Figure 5-12: The Distribution of Realistic Estimates of Global Hepatitis (All Types) Therapeutics Market Potential: 2006

Figure 5-13: The Distribution of Realistic Estimates of Global Hepatitis (All Types) Therapeutics Market Potential — Vaccines: 2006

Figure 5-14: The Distribution of Realistic Estimates of Global Hepatitis (All Types) Therapeutics Market Potential — Antiviral Drugs: 2006

 

    Cell and Gene Therapy Market Dynamics by Disease Type: Development, Trends, and Forecasts, 4th Edition (2024-2030)
    April 11, 2025
    Cell and Gene Therapy Market Deals: Investment, M&A, and Partnerships, 2021-2025 (3rd Edition)
    February 13, 2025
    Cell and Gene Therapy Deals Analysis, 2021-2024
    June 3, 2024
    Cell Therapy and Gene Therapy Markets (Markets by Disease Type), 2023-2029
    April 30, 2024

Related products

  • Placeholder image

    Drug Delivery Technology and Applications: A summary of Kalorama’s market research, 2001-2003

    $746.00 – $1,492.00
  • Placeholder image

    Medicare Reform and the Pharmaceutical Industry: Implications of the Medicare Prescription Drug Improvement and Modernization Act of 2003

    $795.00 – $1,590.00
  • Placeholder image

    Early Stage Drug Discovery 2004: Combi-chem & High Throughput Screening Revisited

    $2,995.00 – $5,990.00
  • Placeholder image

    Cardiovascular Disease: The 45 Market in the United States for Drugs and Medical Devices

    $2,995.00 – $5,990.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025
  • IVD Trends to Watch: Personalized Medicine Adds Precision to Diagnostic Testing January 2, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
Diagnostic Equipment Service Conundrum – How Much Is Too Much?, How Little...Orthopedic Biomaterials, The World Market, 2nd Edition
Scroll to top